Amendment (S.Amdt.2108) to S.3187: A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes.

Back to Main Bill Page
Back to Roll Call Details

May 24, 2012 Roll call number 106 (Amendment number S.Amdt.2108) in the Senate
Question On the Amendment S.Amdt. 2108 to S. 3187 (No short title on file) Amendment purpose To prohibit approval by the Food and Drug Administration of genetically engineered fish unless the National Oceanic and Atmospheric Administration concurs with such approval.
Ayes: 46 (Democrat: 35; Republican: 9; Other: 2)
Nays: 50 (Democrat: 15; Republican: 35)
Abstained: 4 (Democrat: 1; Republican: 3)
Required percentage of 'Aye' votes: 3/5 (60%)
Percentage of 'aye' votes: 46%
Result: Amendment Rejected

Democrats Voting 'Abstain'

NameVoted
Sen. Richard Blumenthal [D, CT] Abstain

* - Voters marked "No Data" are voters that THOMAS has not associated yet.

** Because of incomplete data from newly elected Representatives, party breakdown visualizations may be inaccurate by one or two votes.

OpenCongress is a free and open-source project of the Participatory Politics Foundation, a 501(c)3 non-profit organization with a mission to increase civic engagement. The non-profit Sunlight Foundation is the Founding and Primary Supporter of OpenCongress.